Immunome IMNM Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's accrued expenses?
- Immunome (IMNM) reported accrued expenses of $21.88M in Q1 2026.
- How has Immunome's accrued expenses changed year-over-year?
- Immunome's accrued expenses increased by 23.9% year-over-year, from $17.66M to $21.88M.
- What is the long-term trend for Immunome's accrued expenses?
- Over 5 years (2020 to 2025), Immunome's accrued expenses has grown at a 97.9% compound annual growth rate (CAGR), from $1.37M to $41.65M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.